When was Sharp Biomedical founded?

Sharp Biomedical was founded in 2024 and raised its 1st funding round 2 years after it was founded.

Where is Sharp Biomedical located?

Sharp Biomedical is headquartered in Edina, United States.

Is Sharp Biomedical a funded company?

Sharp Biomedical is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Oct 12, 2026.

When was the latest funding round of Sharp Biomedical?

Sharp Biomedical's latest funding was a $***** Seed round on Oct 12, 2026, with participation from 1 investor. Its primary sector is Orthopedics. In United States, the Orthopedics sector has seen $2.64B in funding in 2026 to date.

Where does Sharp Biomedical rank among its competitors?

Sharp Biomedical ranks 58th amongst 53 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sharp Biomedical, which secured an undisclosed amount in Oct, 2026.

Who are the top competitors of Sharp Biomedical?

Sharp Biomedical's top competitors include Spineart, Neo and Amber Implants. Among them, Sharp Biomedical secured the most recent funding round in October, 2026.

Sharp Biomedical - 2026 Company Profile, Funding & Competitors

Sharp Biomedical is a seed company based in Edina (United States), founded in 2024. It operates as a Developer of minimally invasive spinal fixation medical device hardware systems. Sharp Biomedical has raised an undisclosed amount in funding from gener8tor 1889. The company has 53 active competitors, including 12 funded and 1 that has exited. Its top competitors include companies like Spineart, Neo and Amber Implants.

Company Details

Developer of minimally invasive spinal fixation medical device hardware systems. This technology enables spinal fusion procedures to occur within outpatient settings through small incisions. The device design reduces tissue damage and bone dissection requirements compared to traditional surgical methods. These instruments facilitate shorter recovery durations for patients undergoing stabilization procedures.

Key Metrics

Founded Year

2024

Location

Edina, United States

Stage

Seed

Latest Funding Round

Seed, Oct 12, 2026, $*****

Investors

gener8tor 1889

Ranked

58^th among 59 competitors

Similar Companies

Spineart & 35 more

View Sharp Biomedical's full profile

Sharp Biomedical has raised funding over 1 round. Its latest funding round was a Seed round on Oct 12, 2026 for $*****. 1 investor participated in its latest round. Sharp Biomedical has 1 institutional investor.

Here is the list of recent funding rounds of Sharp Biomedical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 12, 2026	7464104	Seed	8388556	1109409	4588415	2493861

Access funding benchmarks and valuations. Sign up today!

View details of Sharp Biomedical's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sharp Biomedical include Spineart, Neo and Amber Implants. Here is the list of Top 10 competitors of Sharp Biomedical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Spineart 2005, Plan les Ouates (Switzerland), Series B	Manufacturer of spinal implants and robotic systems for surgical procedures	$139M	EGS Beteiligungen, Gimv & 1 others	61/100
2nd	Neo 2014, Switzerland, Series B	Developer of a surgical instrument for spinal surgeries	$102M	Boundary, Swisscom & 7 others	59/100
3rd	Amber Implants 2015, Delft (Netherlands), Series A	Developer of spinal implants for vertebral fracture	$10M	Blue Sparrows MedTech Fund, Europa	53/100
4th	Elevation Spine 2015, Monterey (United States), Series B	Developer of interbody spinal fusion implants	$11M	Technology Venture Partners, Mutual Capital Partners ... Read more	52/100
5th	Spinal Simplicity 2008, Lenexa (United States), Series B	Developer of minimally invasive devices for spinal problems	$21.1M	Cantilever Investors, Nueterra Capital & 3 others	47/100
6th	FloSpine 2011, Boca Raton (United States), Seed	Developer of spinal implants and instruments for orthopedic surgeries	$2.23M	-	46/100
7th	Spinal Resources 2005, Fort Lauderdale (United States), Unfunded	Provider of minimally-invasive spinal systems for reconstruction of spinal fusion	-	-	46/100
8th	Xenix Medical 2016, Orlando (United States), Unfunded	Developer of medical devices for spinal fusion surgery	-	-	45/100
9th	Nanovis 2006, Columbia City (United States), Series A	Manufacturer of nano-technology based spinal implants	$16.8M	Elevate Ventures, HHS & 5 others	45/100
10th	NanoHive 2014, Woburn (United States), Series C	Developer of spinal interbody fusion implants	$7M	Kenston Capital Partners	36/100
58th	Sharp Biomedical 2024, Edina (United States), Seed	Developer of minimally invasive spinal fixation medical device hardware systems	-	gener8tor 1889	15/100